Logo-aim
Arch Iran Med. 2020;23(8): 564-567.
doi: 10.34172/aim.2020.61

Scopus ID: 85090493598
  Abstract View: 431
  PDF Download: 313

COVID-19

Review

Diabetes Management during the COVID-19 Pandemic: An Iranian Expert Opinion Statement

Mojtaba Malek 1 ORCID logo, Farhad Hosseinpanah 2 ORCID logo, Hamid Reza Aghaei Meybodi 3 ORCID logo, Seyed Adel Jahed 4 ORCID logo, Farzad Hadaegh 5 ORCID logo, Sasan Sharghi 3 ORCID logo, Alireza Esteghamati 6 ORCID logo, Mohammad E. Khamseh 7* ORCID logo

1 Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology & Metabolism, Iran University of Medical Sciences, Tehran, Iran
2 Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Endocrinology and Metabolism Research Institute (EMRI) Tehran University of Medical Sciences (TUMS), Tehran, Iran
4 Gabric Diabetes Education Association, Tehran, Iran
5 Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6 Endocrine Research Center, Valiasr Hospital, Tehran University of Medical Sciences, Tehran, Iran
7 Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences (IUMS), Tehran, Iran
*Corresponding Author: Mohammad Ebrahim Khamseh, MD; Endocrine Research Center, Institute of Endocrinology and Metabolism, No. 10, Firoozeh St., Valiasr Ave., Vali-asr Sq., Tehran Iran. Tel: +98-21-88945172, Fax: 98-21-88945173, Email: khamseh.m@iums.ac.ir

Abstract

The coronavirus infection is an evolving pandemic with high morbidity and mortality, especially in people with comorbidities. The case fatality rate (CFR) is 9.2% in the presence of diabetes, while it is 1.4% in those without any comorbidity. Diabetes is a prevalent disease globally; hence, healthcare professionals are highly concerned about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic progression. Current evidence does not support higher incidence of coronavirus disease 2019 (COVID-19) in people with diabetes (PWD). However, people with diabetes are considered high risk for developing complications. Optimal metabolic control is a challenging concept, especially in the presence of an acute and severe respiratory viral infection. In this consensus, we considered the challenging issues in management of patients with diabetes during the COVID-19 pandemic. The consensus covers various aspects of outpatient as well as inpatient care based on the current evidence.
Keywords: COVID-19, Diabetes Management, Expert Opinion
Cite this article as: Malek M, Hosseinpanah F, Aghaei Meybodi HR, Jahed SA, Hadaegh F, Sharghi S, et al. Diabetes management during the COVID-19 pandemic: an Iranian expert opinion statement. Arch Iran Med. 2020;23(8):564–567. doi: 10.34172/ aim.2020.61.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 431

Your browser does not support the canvas element.


PDF Download: 313

Your browser does not support the canvas element.

Submitted: 02 May 2020
Accepted: 14 Jun 2020
ePublished: 01 Aug 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)